𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immediate response to botulinum toxin injections in patients with fixed dystonia

✍ Scribed by Mark J. Edwards; Kailash P. Bhatia; Carla Cordivari

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
880 KB
Volume
26
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

originating from the peripheral rather than central retina. Correspondingly, VEP was also reported to be normal in MSA patients as it measures activity mainly originating from the central visual field. 7 Future studies will have to determine whether MSA patients show predominantly peripheral visual field defects.

πŸ“œ SIMILAR VOLUMES

Botulinum toxin injections reduce associ
Botulinum toxin injections reduce associative plasticity in patients with primary dystonia
✍ Maja Kojovic; Antonio Caronni; Matteo Bologna; John C. Rothwell; Kailash P. Bhat πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 373 KB

## Abstract Botulinum toxin injections ameliorate dystonic symptoms by blocking the neuromuscular junction and weakening dystonic contractions. We asked if botulinum toxin injections in dystonia patients might also affect the integrity of sensorimotor cortical plasticity, one of the key pathophysio

A rare case of laryngeal dystonia associ
A rare case of laryngeal dystonia associated with neurosyphilis: Response to botulinum toxin injection
✍ Ki-Hong Kevin Ho; Christopher C. Wright; Michael P. Underbrink πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 139 KB

## Abstract We report a unique case of laryngeal dystonia in a 43‐year‐old male with neurosyphilis who underwent successful treatment with botulinum toxin injection. To date there have been no reports of laryngeal dystonia associated with neurosyphilis. The patient initially presented with strained

Response to botulinum toxin F in seroneg
Response to botulinum toxin F in seronegative botulinum toxin Aβ€”resistant patients
✍ Dr. Paul E. Greene; Stanley Fahn πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 342 KB

## Abstract Botulinum toxin type A (btx A) injections are the most effective treatment for most patients with focal dystonia. Some patients who improve after btx A injections and later lose response have serologic evidence of antibodies to btx A with the mouse neutralization assay (seropositive pat

Use of botulinum toxin type F injections
Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A
✍ Dr. Paul E. Greene; Stanley Fahn πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 492 KB

## Abstract Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after

Secondary nonresponsiveness to botulinum
Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia
✍ Charles H. Adler; Stewart A. Factor; Mitchell Brin; Kapil D. Sethi πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 77 KB

## Abstract Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6‐year